Medical Weight Loss Training provides you with our FREE Medical Weight Loss Certification Training Manual. Please contact us for your complete online training for Physicians, Physician Assistants (PA), Nurse Practitioners (NP) and Registered Nurses (RN). How to start a medically supervised weight loss clinic: a Beginner’s Guide to Prescription Medications. Are you a healthcare provider . . .
Originally posted in Medical Weight Loss Training Big news in the world of weight loss treatments—Tirzepatide is officially off the FDA’s drug shortage list as of October 2nd, 2024. That’s right, we’re stepping into a new era of how it’s prescribed, compounded, and distributed. Let’s break down what you need to know about the FDA’s . . .
Originally posted on Medical Weight Loss Training. Recently, the FDA changed the availability status of most forms of semaglutide and tirzepatide from its drug shortage list to “Available”. This move has significant implications for those of us in the weight loss and aesthetics industry, especially if you’ve been leaning on compounded copy versions of these drugs . . .
Are you intrigued by the potential of Tirzepatide (Mounjaro® and Zepbound), a rising star in the field of medical weight management? If you’re eager to revolutionize your approach and offer patients a comprehensive solution, you’re about to delve into the right resource. Welcome to a world of insights that could reshape your medical practice – . . .
Have you ever wondered how the groundbreaking medications Tirzepatide (MOUNJARO®/ZEPBOUND) and Semaglutide (OZEMPIC®/WEGOVY®) measure up in the battle against obesity? If you’re eager to discover the nuanced differences, potential advantages, and the science driving these two giants of weight loss treatment, you’re in for a rewarding read. This article unravels the intricacies of comparing Tirzepatide . . .
